Hany A Abdel-Hafiz

6PUBLICATIONS
22CO-AUTHORS
Cancer geneticsHaematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2025
Concurrent loss of the Y chromosome in cancer and T cells impacts outcome.

Xingyu Chen, Yiling Shen, Suhyeon Choi

|Jun 21, 2023
Y chromosome loss in cancer drives growth by evasion of adaptive immunity.

Hany A Abdel-Hafiz, Johanna M Schafer, Xingyu Chen

|Nov 28, 2020
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy.

Megan M Tu, Hany A Abdel-Hafiz, Robert T Jones

|Feb 26, 2019
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.

Megan M Tu, Francis Y F Lee, Robert T Jones

Pageof 1